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INTRODUCTION 
Biomedical  imaging  has  been  undergoing  rapid 
technological advancements over the last several decades 
and has seen the development of many new applications. 
Techniques  such  as  functional  imaging,  spectroscopic 
imaging,  optical  imaging,  and  image-guided 
interventional  techniques  (treatment  and  therapy)  have 
been  gaining  acceptance  in  areas  ranging  from  basic 
research  to  clinical  applications,  and  from  the  cellular 
level to the whole-organ level. Biomedical imaging is an 
interdisciplinary field that requires collaboration among 
biologists,  chemists,  medical  physicists, 
pharmacologists,  computer  scientists,  biomedical 
engineers,  and  clinicians  of  all  specialties.  Skills  and 
tools provided by radiologists are at the centre of many 
clinical  research  programs  [1].  Biomedical  imaging  is 
increasingly  emerging  as  an  essentially  basic  clinical 
investigational tool. Furthermore, imaging is becoming 
increasingly  important  as  an  approach  to  synthesise, 
extract  and  translate  useful  information  from  large 
multidimensional  databases  accumulated  in  research 
frontiers  such  as  functional  genomics,  proteomics,  and 
functional imaging [2]. 
BIOMEDICAL IMAGING RESEARCH-FRONTIER AREAS 
Functional, metabolic and molecular imaging 
Due to rapid technological developments leading to 
high spatial and temporal resolution, ultrasound, CT and 
MRI offer many opportunities for performing functional 
assessment  of  different  body  systems.  The  emergence 
and  development  of  functional  MR  imaging  and 
radionuclide imaging (SPECT/PET) have revolutionised 
the  study  of  the  functions  of  many  body  systems. 
Functional  magnetic  resonance  (MR)  encompasses  a 
spectrum  of  techniques  that  depict  physiological  and 
molecular  processes  before  morphological  changes  are 
visible  on  conventional  imaging.  Intraoperative  MR 
guidance for neurosurgery improves prevision of tumour 
resection with use of combined data between functional 
MRI and SPECT [3]. 
MR spectroscopy is considered to be a method of 
molecular  imaging.  The  ability  to  break  down  the 
chemical  composition  of  a  lesion  has  contributed 
significant  information  to  the  understanding  of  the 
metabolic  process  of  normal  and  pathological  tissues. 
The techniques most often used in clinical practice are 
proton  spectroscopy  (
1HMRS)  [4,  5]  and  phosphor 
spectroscopy (
31PMRS) [6]. The former techniques give 
various information about acethylaspartate acid-neuronal 
cell health marker, creatinin-related to metabolic change, 
choline-element  of  cell  membrane  turnover,  lactates-
marker  of  anaerobic  metabolism,  and  lipid-marker  of 
mobile lipids. The latter technique offers evaluation of 
energetic condition of the cells, phosphate compounds, 
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mono-biphosphate,  phosphocreatinin,  and  adenosine 
triphosphate ATP [7]. With rapid advances in technology 
over the last decade, MR spectroscopy has entered the 
clinical routine [8, 9], and is now routinely used as an 
adjunct method to MRI for the pre-therapeutic diagnosis, 
assessment  of  therapy  response,  and  therapeutic 
monitoring of brain, breast, and prostate cancer [10–14]. 
The relative concentrations of key chemical constituents 
such as citrate, choline and creatinine can be displayed 
on  MR  spectroscopy  examination.  In  addition,  MR 
spectroscopy has been used to help in the estimation of 
tumour  volume,  extracapsular  extension  and  post-
radiotherapy recurrence [15, 16]. 
PET and SPECT are powerful techniques capable of 
imaging biochemical processes in vivo in real-time. The 
use of PET and SPECT lies in monitoring the presence 
and  activity  of  disease  as  a  function  of  treatment, 
particularly in oncology. New functional and metabolic 
imaging  techniques,  especially  hybrid  SPECT/CT, 
PET/CT and PET/MRI, provide pathological information 
in  addition  to  morphological  information.  Combined 
PET/CT offers superior advantages over each individual 
imaging modality and has been shown to be valuable in 
many applications such as cardiac imaging [17]. It has 
been reported that PET/CT allows more precise detection 
and  localisation  of  coronary  artery  disease  than 
individual PET or CT imaging modalities [18–20]. 
Molecular imaging is a diagnostic method based on 
the observation of cells and molecular structures in vivo 
using  different  imaging  modalities  and  new  diagnostic 
and therapeutic markers. Scintigraphy is in the forefront 
of  molecular  imaging  because  it  can  directly  visualise 
molecular events occurring at subnanomolar to milimolar 
levels.  Findings  in  PET  and  SPECT  will  continue  to 
direct the progress of molecular imaging [21]. Molecular 
imaging  contributes  to  biomedical  research  and 
development  in  many  ways.  In  clinical  practice, 
molecular imaging technologies may allow the detection 
of  some  disease  processes  years  before  they  cause 
symptoms or before they would have been detected by 
means  of  conventional  diagnostic  tests  or  imaging 
modalities  [22].  Molecular  imaging  enables  the 
visualisation  of  molecular  events  and  improves 
understanding  of  the  drug  actions  within  the  body 
systems. Biomarkers at the molecular level could allow 
physicians  to  tailor  therapy  to  the  unique  molecular 
profile of a patient or a disease, such as cancer [23]. 
Biomedical optical imaging 
Optimal  imaging  techniques  use  light  emitted 
through  fluorescence  or  bioluminescence.  Biomedical 
optical  imaging  is  used  to  investigate  tissues  from  the 
organelle  level  to  the  organ  level,  to  assist  in  the 
detection,  diagnosis,  and  treatment  of  pathological 
processes in noninvasive or minimally invasive ways to 
the  body.  Applications  of  biomedical  optical  imaging 
range  from  the  use  of  fluorescent  and  bioluminescent 
techniques  to  help  identify  biomolecular  distributions 
within cells, to micrometre-scale cross-sectional imaging 
of  the  retina,  to  imaging  and  selective  treatment  of 
tumours [24, 25]. Because of the limited penetration of 
light in tissue, the large amount of photon scattering, and 
the need to transfect cells, neither bioluminescence nor 
fluorescence  imaging  is  likely  to  become  widely 
accepted. 
New  optical  imaging  techniques  include  optical 
coherence  tomography,  multiphoton  microscopy,  total 
internal reflection fluorescence, and speckle microscopy. 
Research priorities that are currently being performed or 
will be targeted include: in vivo imaging at cellular level, 
to  evaluate  early  neoplastic  changes,  to  enhance 
molecular  imaging  performance,  to  develop  novel 
imaging devices such as image-guided biopsy probes or 
devices for imaging inside the body, and portable low-
cost optical imaging methods for brain function (3).  
Computerised analysis of medical images-computer 
aided detection and diagnosis 
The  classic  computer  applications  are  computer-
aided detection and computer-aided diagnosis (CAD) in 
mammography, lung and colon cancer [26–33]. 
Screening mammography was the first modality to 
benefit from CAD and clinical studies of CAD system 
have  been  conducted  successfully  to  demonstrate  the 
additional  value  it  offers  for  the  detection  of  breast 
cancer.  The  currently  accepted  model  for  CAD  in 
mammography is to use it as a “second reader”—that is, 
the radiologist first searches the images for masses and 
microcalcifications,  and  then  the  computer  assists  the 
radiologist to identify additional suspicious regions that 
may be cancerous, with the final diagnosis and decisions 
concerning  patient  care  being  made  by  the  radiologist 
[26,  27].  Use  of  CAD  in  the  diagnostic  work-up  may 
prevent a malignant lesion from being misclassified as 
benign by the radiologist. It has also been reported that 
CAD  can  even  improve  cancer  detection  over  double-
read mammograms [28]. A recent systematic review of 
CAD in cancer imaging diagnosis reported that the use of 
CAD  significantly  improved  the  mean  sensitivity, 
specificity and diagnostic odds ratio of cancer diagnosis 
using  mammography  and  breast  ultrasound  compared 
with  radiologists  alone  using  the  mammography  and 
breast ultrasound methods [34]. 
The early detection and removal of colonic polyps 
can  substantially  reduce  the  risk  of  developing  colon 
cancer.  CT  colonography,  or  virtual  colonoscopy,  has 
shown promise as a minimally invasive technique to help 
detect  polyps  [29,  30].  Manual  reading  of  CT 
colonography images is increasingly prone to errors due 
to the high number of images to be analysed, which may 
lead  to  reader’s  fatigue  [35].  Moreover,  image 
interpretation  is  subjected  to  reader’s  bias  and  no 
systematic method has been designed so far for lesion 
visualisation [36]. Furthermore, there is a steep learning 
curve for the reader to acquire competence with image 
interpretation. CAD fulfills the role as a second reader 
and  it  has  been  shown  to  achieve  high  sensitivity  for 
detecting  colonic  polyps.  CAD  improves  radiologists’ 
accuracy in detecting polyps and classifying the feature 
of polyps, by acting as a second reader to enhance the Sun et al. Biomed Imaging Interv J 2011; 7(3):e21    3 
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radiologists’  performance  in  interpreting  CT  virtual 
colonoscopic  examinations,  especially  for  less-
experienced readers [29–31, 37]. 
The detection of subtle focal pulmonary opacities on 
chest  radiograph  and  CT  remains  a  challenge.  While 
screening and related studies have shown that CT is very 
sensitive for the detection of lung nodules, it is not very 
specific for the detection of lung cancers. Hence, there is 
substantial interest in the development of CAD systems 
to assist radiologists with the detection of nodules as well 
as  characterisation  of  detected  nodules  as  benign  or 
malignant.  CAD  techniques  are  developed  to  improve 
interpretation  in  chest  imaging  with  the  aim  of 
decreasing  the  intrinsic  limitations  and  variations  of 
human  perception  by  alerting  the  reader  to  suspicious 
areas in chest radiographs and CTs [32, 33].  
Studies  have  shown  that  CAD  systems  have 
improved the sensitivity  in the detection of pulmonary 
nodules, especially for nodules smaller than 5 mm on CT 
examinations,  which  are  often  overlooked  by  visual 
inspection  alone  [32,  33].  The  CAD  technique  can  be 
used  as  a  complementary  tool  that  draws  radiologists’ 
attention  to  certain  image  areas  that  need  further 
evaluation.  However,  according  to  a  recent  systematic 
review of the effectiveness of CAD in cancer imaging, 
Eadie et al. found that using CAD to detect lesions on 
images  provided  less  added  value  to  radiologists  than 
CAD diagnosis [34]. Thus, it seems likely that the newer 
generation  of  commercial  CAD  systems  will  be  CAD 
diagnosis-based, which indicates the beneficial effects of 
CAD  to  radiologists  by  advising  the  status  of  the 
abnormality. 
Image-guided intervention and therapy 
Biomedical imaging has played an important role in 
identifying and monitoring the effectiveness of the best 
treatments  for  many  diseases.  The  ultimate  goal  of 
treatment  is  to  identify  the  target  of  treatment  and  to 
deliver the maximum therapy to that target with minimal 
or no damage to the normal cells. Image-guided surgery 
improves the accuracy of many surgical procedures by 
eliminating much of the speculation, reducing the risk of 
human  error,  and  minimising  variations  among  the 
abilities of individual physicians [38, 39]. Image-guided 
therapy  for  cancer  has  improved  local  treatment  and 
reduced  the  complication  rate.  With  the  advent  and 
increasing  application  of  robotics  in  conventional 
surgery,  image-based  navigational  techniques  are 
becoming  more important and are expected to provide 
even better surgical outcomes in patients [40]. 
Real-time  imaging  guidance  by  means  of  CT, 
ultrasound  or  MRI  is  performed  for  various  treatment 
options  such  as  minimally  invasive  image-guided 
thermal  ablation  therapies  for  tumours  of  the  liver, 
kidney,  lung  and  bone  (3).  Image-guided  minimally 
invasive therapies of the future may include the delivery 
of other therapeutics, including proteins, stem cells, gene 
therapies, chemotherapeutic agents and antibodies (3).  
BIOMEDICAL IMAGING AND INTERVENTION JOURNAL 
OFFERS AN OPPORTUNITY FOR INTEGRATION OF 
RESEARCHERS FROM DIFFERENT DISCIPLINES 
The  Biomedical  Imaging  and  Intervention  Journal 
(biij, available at http://www.biij.org) is an open access 
multidisciplinary peer-reviewed quarterly online journal, 
published  by  the  Department  of  Biomedical  Imaging, 
University  of  Malaya,  Malaysia.  biij  is  a 
multidisciplinary  journal  covering  all  the  clinical  and 
technical aspects of biomedical imaging and intervention, 
radiotherapy  and  oncology,  minimally  invasive  image-
guided  therapy,  image  processing  and  informatics, 
molecular medicine, medical physics and radiobiology as 
well  as  radiography  and  bioengineering  related  to 
imaging or intervention. Researchers are encouraged to 
fully utilise the biij as a platform for biomedical imaging 
research by publishing their original research works and 
sharing research outcomes with colleagues from the Asia 
Pacific region and the rest of the world. 
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